Many corneal diseases are associated with the development of opacities in the stroma. Corneal haze presents as a superficial opacification of the anterior corneal stroma leading to a transient decrease in corneal transparency after lamellar keratectomy for dermoid, corneal inclusion cyst and corneal tumor, corneoconjunctival transposition or autologous lamellar keratoplasty for deep corneal ulcer in veterinary ophthalmology. Also, it is one of the most important complications of photorefractive keratectomy (PRK), and its incidence and intensity increase in eyes treated for higher degrees of refractive error in human medicine \[[@r12]\]. In most transparency disorders, corneal haze may be induced by a combination of two or more predominant factors like corneal edema, scarring, accumulated macromolecules and reflective keratocytes \[[@r23]\]. Moreover, the formation of corneal haze involves the apoptosis of keratocytes and the proliferation and transformation of fibroblasts into myofibroblasts \[[@r30]\]. Therefore, one of the most crucial aspects of corneal healing from refractive surgery is the minimization of corneal haze.

The efficacy of mitomycin C (MMC) in reducing the incidence of corneal haze has led to its widespread use in most refractive surgery practices \[[@r29]\]. However, multiple complications, such as limbal/scleral necrosis, abnormal wound healing and loss of keratocytes, are reported with the topical use of MMC \[[@r25]\]. These results encourage the development of newer pharmacologic agents that can effectively inhibit the formation of corneal haze without causing serious side effects. Recent research on trichostatin A (TSA), a histone deacetylase inhibitor, reported that it inhibits TGF-β1-induced accumulation of the extracellular matrix and myofibroblast formation *in vitro* and markedly decreases haze *in vivo* \[[@r28]\]. However, there are no commercially available products for clinical use.

*Allium cepa* (onion) and onion extract have been reported to be effective in cardiovascular disease, because of their hypolipidemic, anti-hypertensive, anti-diabetic and antithrombotic effects, and to possess many other biological activities including antimicrobial, antioxidant, anticarcinogenic and immunomodulatory activities \[[@r6]\]. Especially, flavonoids in onion extract reduce scar formation by inhibiting fibroblast activities \[[@r4]\]. Recently, commercial products composed of onion extract have been used to reduce hypertrophic scar formation \[[@r13]\]. Myofibroblasts are an important cell in connective tissue remodeling that differentiates during wound healing and fibrosis development in the pathogenesis of such diseases as hypertrophic scars, liver or pulmonary fibrosis \[[@r8]\], and corneal haze formation \[[@r20]\]. The myofibroblasts could represent an important target for corneal haze treatment like in the treatment for hypertrophic scar formation. Thus, onion extract could be useful as a therapeutic in preventing the development of corneal haze by suppressing the differentiation of fibroblasts into myofibroblasts.

Air assisted lamellar keratectomy is one of the experimental models for the development of corneal haze \[[@r18]\]. In this method, the wound size and depth were standardized by modification of the bubble technique for corneal transplantation. Also, it could induce more corneal haze than the conventional superficial keratectomy.

The aim of this study was to evaluate the efficacy of onion extract ointment in corneal haze development after applying to the haze model with the air assisted lamellar keratectomy for canine eyes. In addition, the effect of onion extract ointment in the down-regulation of myofibroblast expression was examined with immunohistochemistry using the α-SMA antibody.

MATERIALS AND METHODS {#s1}
=====================

*Corneal fibroblast culture and cell viability test for onion extract*: Corneal fibroblasts were cultured from porcine eyes, which were obtained from a local slaughterhouse, for the cell viability test of the onion extract. The corneal buttons removed by an 8-mm diameter trephine (Barron radial vacuum trephine, Katena products, Inc., Denvile, NJ, U.S.A.) were obtained. After then, the epithelial cells of the corneal buttons were scrapped off using a \#10 scalpel blade, Descemet's membranes were peeled off, and the corneal stromas were washed with phosphate buffered saline (PBS, pH 7.4) (10010-023, GIBCO^TM^, Grand Island, NY, U.S.A.). The corneal buttons were cut into four small pieces and incubated overnight in a humidified CO~2~ incubator at 37°C in Dulbecco's modified Eagle's medium (DMEM) (11995-065, GIBCO^TM^) containing 20 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES, 15630-080, GIBCO^TM^) and 1.25 mg/m*l* collagenase type I (17100-017, GIBCO^TM^). The digested tissues were mixed with media by pipetting and filtered a 100 *µ*m cell strainer (08-771-19, Falcon^TM^, Franklin Lakes, NJ, U.S.A.). Then, they were centrifuged at 800 g for 5 min and resuspended in 2 m*l* of DMEM containing 20 mM HEPES, 50 *µ*g/m*l* gentamicin (15750-078, GIBCO^TM^), 1.25 *µ*g/m*l* amphotericin B (A20678, GIBCO^TM^) and 10% fetal bovine serum (10437-028, GIBCO^TM^). This keratocyte-containing cell suspension was then seeded on 6-well plastic dishes and incubated in a humidified CO~2~ incubator at 37°C. Eighty percent confluent cultures of cornea fibroblasts (passages 1--3) were used for experiments.

Trypan blue dye exclusion test was used to evaluate cell viability of corneal fibroblasts after treating onion extract. Onion extract (W281719, Sigma-Aldrich, St. Louis, MO, U.S.A.) was treated to the each well at 0, 0.01, 0.1, 1, 10, 50 and 100 *µl*/m*l* concentrations diluted with DMSO (AMR-0231-1; Amresco, Solon, OH, U.S.A.) for 24 hr. Then, they were resuspended using 0.05% trypsin/0.53 mM EDTA (25300-054, GIBCO^TM^), and trypan blue solutions (0.4% wt/vol, 15250-061, GIBCO^TM^) were mixed with the resuspension cells. The suspensions were loaded into a hemocytometer and scored with a light microscope. Cells that stained blue were scored as nonviable.

*A process of manufacture for the onion extract ointment*: A 1% onion extract ointment was made with 10 g white petrolatum (white petrolatum 1 g/g, Sungkwang Pharm., Cheonan, Korea) and 0.1 m*l* onion extract (W281719, Sigma-Aldrich) mixture in a water bath. The concentration of onion extract ointment depended on the *in vitro* viability test. Before use in a main study, the onion extract ointment was applied BID for 2 weeks at the normal cornea of six healthy beagle dogs to test the abnormal allergic reactions (blepharospasm, conjunctival hyperemia, corneal epithelial disorders and other ocular abnormality) by ophthalmic examinations every the other days.

*Animals*: Twenty-four eyes from 12 healthy beagles were used in this study. Before the experiment, all dogs underwent an ophthalmic examination including slit-lamp biomicroscopy (SL-D7, Topcon, Tokyo, Japan), indirect ophthalmoscopy (Vantage plus, Keeler, Windsor, U.K.), rebound tonometry (Tonovet, Tiolat, Helsinki, Finland), Schirmer's tear test (Schirmer tear test, Intervet, Summit, NJ, U.S.A.) and fluorescein staining (Fluorescein paper, Haag Streit AG, Koeniz, Switzerland). Dogs with ocular or systemic diseases were excluded. The animal use and experimental protocols were approved by the Institutional Animal Care and Use committee (SNU-121123-10; Seoul National University, Korea). All dogs were divided into 4 groups consisting of 6 eyes in each group; control (Group C; n=6), Prednisolone acetate treatment (Group P; n=6), Onion extract treatment (Group O; n=6) and TGF-β1 treatment (Group T; n=6).

*Corneal Haze Generation by the air assisted lamellar keratectomy*: Air assisted lamellar keratectomy was performed following a method reported previously \[[@r18]\]. General anesthesia was accomplished by intravenous injection of tiletamine and zolazepam (Zoletil, Virbac, Carros, France; 2.5 mg/kg) for induction and maintained with isoflurane (Ifran, Hana Pharm, Seoul, Korea; MAC 0.5--1.5%). Atracurium (ATRA, Hana Pharm; 0.01 mg/kg, IV) was administrated for central positioning of the cornea during the surgery. The air assisted lamellar keratectomy was performed for all eyes. Briefly, the center of the cornea was trephined 375 *µ*m using an 8 mm diameter trephine (Barron radial vacuum trephine, Katena) ([Fig. 1A](#fig_001){ref-type="fig"}Fig. 1.The air assisted lamellar keratectomy. (A) The center of the cornea was trephined 375 *µ*m using an 8 mm vacuum trephine. (B) Four m*l* of air was injected at the base of the trephination gutter into the corneal stroma using a 30-gauge needle attached to a syringe. (C) Intrastromal blanching was observed, and the blanched cornea was removed using a corneal dissector and blunt-tipped corneal scissors. (D) Appearance after keratectomy using the air assisted lamellar keratectomy.). The surgical field was kept dry after the trephination to minimize stromal edema. Four m*l* of air were injected at the base of the trephination gutter into the corneal stroma using a 30-gauge needle attached to a syringe. The needle was bent 5 mm from its tip so that the terminal segment angled upwards approximately 60°, while the bevel faces up ([Fig. 1B](#fig_001){ref-type="fig"}). The tip was introduced parallel to the corneal surface into the central stroma at the base of the trephination groove. The plunger of the air-filled syringe was pressed until intrastromal blanching was observed ([Fig. 1C](#fig_001){ref-type="fig"}). The fuzzy region of the white opaque cornea was removed using a corneal dissector and blunt-tipped corneal scissors ([Fig. 1D](#fig_001){ref-type="fig"}).

After surgery, one drop of atropine (1%, Isopto Atropine, Alcon, Antwerp, Belgium) was applied for 3 days for the purpose of analgesic effect. Levofloxacine (0.5%, Cravit, Santen, Osaka, Japan) eye drops were administered three times daily until 7 days after the surgery. After the seventh day, artificial tear eye drops (0.1% sodium hyaluronate; Lacure, Samil Pharm., Seoul, Korea) for group C, prednisolone acetate 1% (Pred-Forte, Allergan, Irvine, CA, U.S.A.) for group P, an onion extract (W281719, Sigma-Aldrich, St. Louis, MO, U.S.A.) ointment 10 m*l*/mg diluted with a white petrolatum (Vaseline, SungKwang Pharm, Cheonan, Korea) for group O and TGF-β1 (T7039, Sigma-Aldrich) 1 *n*g/m*l* diluted with artificial tear eye drops for group T were administered 3 times daily each for 3 weeks. *Corneal Haze Grading:* The level of haze in the cornea was evaluated by slit lamp biomicroscopy (SL-D7) at 7, 14, 21 and 28 days after the surgery using two kinds of methods: the previously reported clinical grading system \[[@r10]\] and a quantitative method. With the clinical grading, grade 0 was a completely clear cornea; grade 0.5 had a trace amount of haze observed with careful oblique illumination; grade 1 was a mild obscuration of the iris details; grade 2 was a more prominent haze not interfering with the visibility of fine iris details; grade 3 was a moderate obscuration of the iris and lens; and grade 4 was complete opacification of the stroma in the area of the ablation. Haze grading was performed in a blinded manner by three independent veterinarians.

For quantitative haze grading, slit images were taken under standardized conditions: a 1 mm wide, 14 mm long slit beam and a 45° angle from the temporal aspect of the cornea without background illumination. Then, each photograph was converted into an 8 bit gray-scale image using digital image analysis (ImageJ ver. 1.46r; http://rsbweb.nih.gov/ij/). The selected area of the corneal section (100 × 3 pixel) was isolated, and an intensity of 0 to 255 was determined by averaging the gray-scale (intensity) indices of the individual pixels within the area. Total intensity levels within the selected area were measured.

*Immunofluorescence Analyses*: The beagle eyes were enucleated with the conventional trans-scleral method after euthanasia. Corneas were excised 2--3 mm from the limbus with forceps and tenotomy scissors. And then, the samples were fixed in 10% buffered formalin and embedded in paraffin. Immunofluorescence staining for α-smooth muscle actin (SMA), a marker for myofibroblasts, was performed. Tissue sections (4 *µ*m) were incubated at room temperature with the monoclonal antibody for α-SMA (M085101, DAKO, Carpinteria, CA, U.S.A.) at a 1:200 dilution in 1× PBS for 90 min and with a secondary antibody (Alexa Fluor 488 goat anti-mouse IgG; Molecular Probes, Eugene, OR, U.S.A.) at a dilution of 1:500 for 1 hr. Tissues were mounted with mounting medium and DAPI (SlowFade Gold antifade reagent, Molecular Probes) to visualize the nuclei in the tissue sections. Sections were viewed and photographed with a fluorescence microscope (BX51, Olympus, Tokyo, Japan) equipped with a digital camera (DP71, Olympus).

*Quantification of α-SMA-positive Cells*: The α-SMA positive cells in six randomly selected, non-overlapping, full-thickness central corneal columns, extending from the anterior stromal surface to the posterior stromal surface were counted following a method previously reported \[[@r21]\]. The diameter of each column was a 400× microscope field. The images were evaluated using digital image analysis.

*Statistical Analysis*: Statistical analysis was performed with SPSS V20 for Windows (SPSS Inc., Chicago, IL, U.S.A.). Data were expressed as the mean ± standard deviation (SD), and the level of significance was *P*\<0.05. One way analysis of variance (ANOVA) with Bonferroni's post-hoc assessment was used to test for the significance of the objective haze grading and the total green color intensity between the groups. In addition, in one-way repeated measures ANOVA following pairwise comparison, Bonferroni's adjustment was performed to evaluate the objective haze grades against time in the same group. For the clinical corneal haze grading, the values between groups were compared using the Kruskal-Wallis analysis or Friedman test with the Wilcoxon signed rank test.

RESULTS {#s2}
=======

Cell viability was over 95% at the concentration of 0, 0.01, 0.1, 1 and 10 *µl*/m*l* onion extract *in vitro* evaluation (data not shown). The 1% onion extract ointment showed no adverse effects and allergic reaction, like blepharospasm, conjunctival hyperemia, corneal epithelial disorders and other ocular abnormalities, when applied every 12 hr to the normal beagle cornea for 2 weeks.

Corneal haze developed after the air assisted lamellar keratectomy depending on each treatment group ([Fig. 2](#fig_002){ref-type="fig"}Fig. 2.Evaluation of corneal haze with a slit-lamp biomicroscopy. (a) pre-operative evaluation in control group (group C), (b) 7 days after surgery in the group C, (c) 14 days after surgery in the group C, (d) 21 days after surgery in the group C, (e) 28 days after surgery in the group C, (f) pre-operation in 1% prednisolone acetate treatment group (group P), (g) 7 days after surgery in the group P, (h) 14 days after surgery in the group P, (i) 21 days after surgery in the group P, (j) 28 days after surgery in the group P, (k) pre-operation in 1% onion extract ointment treatment group (group O), (l) 7 days after surgery in the group O, (m) 14 days after surgery in the group O, (n) 21 days after surgery in the group O, (o) 28 ays after surgery in the group O, (p) pre-operation TGF-β1 1 *n*g/*μl* treatment group (group T), (q) 7 days after surgery in the group T, (r) 14 days after surgery in the group Y, (s) 21 days after surgery in the group T, (t) 28 days after surgery in the group O.). Control corneas treated with the artificial tear eye drops (group C) had significant developed corneal haze in clinical grading until 21 days after surgery (day 14; *P*=0.032, day 21; *P*=0.041 and day 28; *P*=0.210) compared with day 7 ([Fig. 3](#fig_003){ref-type="fig"}Fig. 3.Clinical corneal haze grading. Mean grades for the clinical evaluation of corneal haze at days 7, 14, 21 and 28 after surgery for each group. ^a,\ b,\ c^Values with a different superscript were significantly different (*P*\<0.05) between groups in the same evaluation day.). Topical application of 1% prednisolone acetate (group P) and 1% onion extract ointment (group O) caused a statistically significant decrease in corneal haze in group P (day 14; *P*=0.021, day 21; *P*=0.012 and day 28; *P*=0.001) and in group O (day 14; *P*=0.037, day 21; *P*=0.008 and day 28; *P*=0.003) compared with the same groups for haze grading at day 7. Additionally, corneal haze was significantly increased in the TGF-β1 treated group (group T) (day 14; *P*=0.002, day 21; *P*\<0.001 and day 28; *P*\<0.001 compared with the haze grading at day 7). For the degree of clinical corneal haze in each group, it decreased in groups P and O from day 14 (day 14; *P*=0.016 and *P*=0.007, day 21; *P*\<0.001 and *P*=0.026 and day 28; *P*=0.001 and *P*=0.011, respectively) compared with group C. In addition, corneal haze significantly increased in group T at days 21 (*P*=0.022) and 28 (*P*=0.001) compared with group C.

Corneal haze was observed beginning 7 days after surgery in all groups and appeared to peak about 21 days after surgery in the control group with an objective evaluation method. The total intensity of the grayscale units for the hazed cornea was significantly increased at days 21 (*P*\<0.001) and 28 (*P*\<0.001) compared with day 7 in group C ([Fig. 4](#fig_004){ref-type="fig"}Fig. 4.Quantification of corneal haze. Total intensity (grayscale unites) levels within the corneal section at days 7, 14, 21 and 28 after surgery for all groups. ^a,\ b,\ c^Values with a different superscript were significantly different (*P*\<0.05) between groups in the same evaluation day.). The total intensity in groups P (day 14; *P*=0.021, day 21; *P*\<0.001 and day 28; *P*\<0.001) and O (day 14; *P*=0.039, day 21; *P*\<0.001 and day 28; *P*\<0.001) was significantly decreased compared with that at day 7. The total intensity of the grayscale units in group T was significantly increased at days 14 (*P*\<0.001), 21 (*P*\<0.001) and 28 (*P*\<0.001) compared with that at day 7.

The corneal haze was significantly decreased in groups P (*P*\<0.001) and O (*P*\<0.001) at day 21, and in groups P (*P*\<0.001) and O (*P*=0.002) at day 28 compared with group C. Furthermore, the corneal haze was significantly increased in group T at days 14 (*P*\<0.001), 21 (*P*\<0.001) and 28 (*P*=0.003) compared with group C.

The results of immunohistochemical staining for α-SMA are shown in [Fig. 5](#fig_005){ref-type="fig"}Fig. 5.Immunohistochemistry for α-smooth muscle actin (SMA) (400× magnification, scale bar=50 *µ*m). (a) stained nucleus with DAPI in control group (group C), (b) α-SMA-positive cells (green color) in the group C, (c) merge image a and b, (d) stained nucleus with DAPI in prednisolone acetate treatment group (group P), (e) α-SMA-positive cells (green color) in the group P, (f) merge image d and e, (g) stained nucleus with DAPI in onion extract treatment group (group O), (h) α-SMA-positive cells (green color) in the group O, (i) merge image g and h, (j) stained nucleus with DAPI in TGF-β1 treated group group (group T), (k) α-SMA-positive cells (green color) in the group T, (l) merge image j and k.. In group C, the corneas exhibited high numbers of α-SMA-positive myofibroblast cells, mostly in the anterior stroma below the epithelium. Topical application of prednisolone acetate (group P) and onion extract (group O) significantly reduced the numbers of α-SMA-positive cells in the stroma. In contrast, TGF-β1 application (group T) significantly increased the numbers of α-SMA-positive cells compared with that in group C.

The total green intensity of the entire stroma was significantly enhanced in group T (*P*\<0.001) compared with that in group C ([Fig. 6](#fig_006){ref-type="fig"}Fig. 6.The total intensity of green color was significantly lower in the prednisolone acetate treatment (group P) and the onion extract treatment (group O) than control (group C). And, the total intensity of green color was significantly higher in the TGF-β1 treatment (group T) than the group C. ^a,\ b,\ c^Values with a different superscript were significantly different (*P*\<0.05).). The total green intensity in groups P (*P*\<0.001) and O (*P*\<0.001) was significantly lower than that in group C.

DISCUSSION {#s3}
==========

Formation of corneal haze involves the apoptosis of keratocytes \[[@r30]\] and transdifferentiation of keratocytes into myofibroblasts in response to endogenous epithelial derived cytokines \[[@r16]\]. TGF-β1 directly activates keratocytes and leads to the formation of myofibroblasts as well as the subsequent reformation of subepithelial stromal tissue \[[@r26]\]. Myofibroblasts scatter more light than that of undifferentiated fibroblasts or keratocytes, not only from their nuclei, but also from their cell bodies and dendritic processes \[[@r23]\]. In addition, this population of cells participates in extracellular matrix remodeling, resulting in a denser and more disorganized extracellular matrix \[[@r15]\]. Intracellular microfilament fibers, such as F-actin and α-smooth muscle actin (SMA), were expressed much higher in myofibroblasts than in keratocytes. These cellular components were enabled myofibroblasts to contract and close wounds, but also rendered the cornea less translucent \[[@r19]\]. Collectively, these changes lead to a loss of corneal transparency.

For a clear cornea, mitomycin C (MMC) is widely used intraoperatively by clinicians to prevent PRK-induced corneal haze, although there are several complications reported with its topical use \[[@r3]\]. There are no effective medicines to control corneal haze, except for MMC treatments. Because the application of steroid eye drop occasionally results in rapid corneal stromal melting, use of these drugs for achieving better corneal transparency is restricted. Thus, we have shown the effects of onion extract ointment in corneal haze prevention and suppression of myofibroblasts from stromal ablation using the air assisted lamellar keratectomy for the development of new treatment and prevention strategies. Corneal fibroblasts were viable in the 10 *µl*/m*l* concentration of the onion extract. There were no adverse effects or allergic reactions for the 1% onion extract ointments. Therefore, we used this concentration of onion extract ointments in this study to evaluate efficacy of onion extract. According to our results, corneal haze grading and expression of α-SMA-positive cells were significantly decreased in the onion extract treated group compared with the control group. Because α-SMA is a specific marker for myofibroblasts, these results suggest that onion extract ointment has suppressive effects on corneal haze.

Treatment with prednisolone acetate showed significant suppression of corneal haze compared with the artificial tear treatment in this paper. Postoperative use of topical corticosteroids has been controversial after PRK. Topically applied steroids, acting as an anti-inflammatory agent, have effectively suppressed corneal haze formation after excimer laser keratectomy in experimental studies \[[@r17], [@r24]\]. But, this reduction in haze appears to be due in part to a delay in the wound-healing response \[[@r24]\]. Also, glucocorticoids increase the lytic action of corneal collagenase, suggesting that this effect might be responsible for the corneal destruction in clinical conditions \[[@r2]\]. Accordingly, the onion extract ointment could be used more safely than steroid eye drops, which would be induced corneal melting.

Onion (*Allium cepae*) extract contains a great amount of antioxidant phytochemicals, sulfur and other numerous phenolic compounds \[[@r1]\]. These compounds have been reported to be effective in cardiovascular diseases because of their hypolipidemic, anti-hypertensive, anti-diabetic and antithrombotic effects, and to possess many other biological activities including antimicrobial, antioxidant, anticarcinogenic, antimutagenic, antiasthmatic, immunomodulatory and probiotic activities \[[@r6]\]. Especially, onion extract was shown to have fibroblast-inhibiting properties, to reduce proliferative activity, and to produce substances in the extracellular matrix \[[@r13]\]. Recently, commercial products composed of onion extract have been used to reduce scar formation on the skin \[[@r13]\]. According to the results of this paper, onion extract suppressed the differentiation of myofibroblasts, and as a result, corneal haze developed significantly less than that of the control. Onion extract would be a good therapeutic candidate as a new medicine for corneal haze suppression.

Mechanical removal of the corneal epithelium and PRK up-regulate TGF-β1 \[[@r11]\]. TGF-β1, a potent profibrotic cytokine, is a key regulator for the differentiation of myofibroblasts during corneal wound healing. It directly activates keratocytes and leads to the formation of myofibroblasts as well as the subsequent reformation of the subepithelial stroma \[[@r11]\]. Consequently, these mechanisms could promote the clinical expression of corneal haze after corneal surgery. In our results, corneal haze was significantly increased by treatments of additional TGF-β1 compared with the control. Furthermore, one experiment showed the prevention of PRK-induced haze through the use of anti-TGF-β1 antibodies \[[@r22]\]. Thus, the suppression of TGF-β1 expression is critical in the prevention of corneal haze.

Fibroblasts differentiate into myofibroblasts through a Smad 2/3 signaling pathway and enhance NADPH oxidases (Nox) 4-derived reactive oxygen species (ROS) signaling cascades \[[@r7]\]. Depletion of Nox4, an essential mediator of Smad2/3 transcription factor activation in response to TGF- β1, down-regulates α-SMA mRNA, and overexpression of Nox4 induces α-SMA expression \[[@r5]\]. The precise mechanisms of onion extract have not yet been completely elucidated. The corneal haze grade was significantly lower in the onion extract treated group than in the control group, and the expression of α-SMA was also down-regulated by the onion extract treatments shown in the results of this study. Among the many flavonoid compounds, quercetin is a major component of onion extract \[[@r27]\], and it has been shown to have powerful antioxidative activity with metal ion binding properties and radical scavenging abilities \[[@r9]\]. In addition, quercetin has a scavenging effect on superoxide anions and hydroxyl radicals, and it prevents lipid peroxidation by blocking the action of xanthine oxidase and chelating iron \[[@r14]\]. These effects could have important roles in the suppressive effect of onion extract against corneal haze formation. These results suggest that onion extract could block TGF-β1 signaling cascades by scavenging ROS to reduce α-SMA expression and subsequently corneal haze development. Further experiments are needed to understand the exact mechanisms of onion extract.

The limitation of this study is that the evaluation time was short and there was not enough to prove exact mechanism of onion extract ointment against corneal haze formation. Therefore, more studies will be needed to understand the mechanisms.

In summary, onion extract ointment could be useful as the therapeutic in the suppression of corneal haze development after applying the air assisted lamellar keratectomy through the down-regulation of fibroblast transdifferentiation into myofibroblasts. This effect could be from the scavenging ability of the onion extract.
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